Accuracy of a Real-Time Continuous Glucose Monitor in Pediatric Diabetic Ketoacidosis Admissions
Description
Objective Continuous glucose monitoring (CGM) devices are integral in the outpatient care of people with type 1 diabetes (T1D), though they lack inpatient labeling. FDA began allowing inpatient use during the COVID-19 pandemic, with some accuracy
